Al-Kindi SG, Janus SE, Neeland IJ, Rajagopalan S, et al. Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States. J Diabetes Complications 2022 Jun 1:108224. doi: 10.1016/j.jdiacomp.2022.108224.
PMID: 35667964